To evaluate whether αGITR, αPD1, or αGITR + αPD1 therapy induces MHC molecules in vivo, we treated GL261-MGH, CT2A, and 005GSC-bearing mice with indicated treatments and measured MHC expression on tumor cells. The gene discussed is HLA-C; the disease is neoplasm.